The patient presented with malignant hypertension, hypokalemia, and an aldosterone‐to‐renin ratio (ARR) of 0.53 indicative of secondary hyperaldosteronism, a condition of excessive renin secretion unresponsive to normal negative feedback mechanisms. Here, REN is linked to malignant hypertension.